CompoundIQ

Disclaimer

CompoundIQ publishes research summaries for informational and educational purposes only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. Always consult a licensed healthcare provider. Many compounds listed are research chemicals not approved for human use.

OtherBeginnerLow Risk

NR (Nicotinamide Riboside)

Also known as: NR, Niagen, Nicotinamide Riboside

Nicotinamide Riboside (NR) is a form of vitamin B3 that serves as an NAD+ precursor. It was the first commercially available NAD+ booster and has more human clinical trial data than NMN. Sold as Niagen by ChromaDex, it has demonstrated ability to raise blood NAD+ levels in multiple human studies.

Evidence50/100 — Moderate

Risk Level

Low Risk

Difficulty

Beginner
CAS Number1341-23-7
Molecular FormulaC11H15N2O5
ClassOther
CategoryLongevity Compounds

Mechanism of Action

NR enters cells via equilibrative nucleoside transporters and is phosphorylated by NR kinases (NRK1/2) to form NMN, which is then converted to NAD+ by NMNAT enzymes. This pathway bypasses the rate-limiting step of the salvage pathway. Elevated NAD+ activates sirtuins and supports PARP-mediated DNA repair, mitochondrial biogenesis, and cellular energy metabolism.

Dosing Research

Standard dose: 300-1000 mg/day orally. Clinical trials have used 100-2000 mg/day. Typically taken once daily in the morning. ChromaDex Niagen recommends 300 mg/day. Higher doses (1000+ mg) have shown safe in clinical studies. No cycling typically required.

Side Effects & Risks

Well-tolerated in clinical trials up to 2000 mg/day. Mild nausea, fatigue, headache, and diarrhea reported by a small percentage. Similar theoretical cancer concern as NMN (no human evidence). Flushing is rare (unlike niacin). Good safety profile based on multiple human studies.

Research Studies

Disclaimer

CompoundIQ publishes research summaries for informational and educational purposes only. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. Always consult a licensed healthcare provider. Many compounds listed are research chemicals not approved for human use.

Send Feedback

Help us improve CompoundIQ